{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:19:18Z","timestamp":1792621158386,"version":"4.5.0"},"reference-count":95,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1001\/jamaoncol.2019.5351","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T14:11:22Z","timestamp":1577974282000},"page":"567","source":"Crossref","is-referenced-by-count":100,"title":["Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases"],"prefix":"10.1001","volume":"6","author":[{"given":"Rachel M.","family":"Glicksman","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Tjong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington F. P.","family":"Neves-Junior","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Hospital S\u00edrio-Liban\u00eas, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L. M.","family":"Chua","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, National Cancer Centre Singapore, Singapore"},{"name":"Oncology Academic Programme, Duke University\/National University of Singapore (NUS) Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mansouri","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin L. K.","family":"Chua","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, National Cancer Centre Singapore, Singapore"},{"name":"Oncology Academic Programme, Duke University\/National University of Singapore (NUS) Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Berlin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff D.","family":"Winter","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Dahele","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Slotman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bilsky","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Multi-Disciplinary Spine Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Shultz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Maldaun","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Hospital S\u00edrio-Liban\u00eas, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Szerlip","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Multi-Disciplinary Spine Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Emilio","family":"Vera-Badillo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Kingston General Hospital, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo N.","family":"Marta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Hospital S\u00edrio-Liban\u00eas, S\u00e3o Paulo, Brazil"},{"name":"Division of Radiation Oncology, Department of Radiology and Oncology, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo, Faculdade de Medicina da Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Y.","family":"Moraes","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Oncology, Kingston General Hospital, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10125","key":"crv190008r1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37?513?025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"crv190008r2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/14737140.2018.1493381","article-title":"The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases.","volume":"18","author":"Vellayappan","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9486","key":"crv190008r3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"issue":"10185","key":"crv190008r4","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"crv190008r5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijrobp.2009.10.056","article-title":"Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center Hospital.","volume":"79","author":"Mizumoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"crv190008r6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cncr.27616","article-title":"Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14.","volume":"119","author":"Howell","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"crv190008r7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jpainsymman.2012.12.002","article-title":"Five things physicians and patients should question in hospice and palliative medicine.","volume":"45","author":"Fischberg","year":"2013","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"crv190008r8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","article-title":"8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up.","volume":"52","author":"Bone Pain Trial Working Party","year":"1999","journal-title":"Radiother Oncol"},{"issue":"2","key":"crv190008r9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijrobp.2009.10.073","article-title":"Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.","volume":"79","author":"Rades","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"crv190008r10","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1200\/JCO.2005.04.754","article-title":"Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.","volume":"23","author":"Rades","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"crv190008r11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/jpm.2012.0376","article-title":"ACR Appropriateness Criteria\u00ae spinal bone metastases.","volume":"16","author":"Lo","year":"2013","journal-title":"J Palliat Med"},{"issue":"3","key":"crv190008r12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/COC.0b013e31826e053d","article-title":"American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of stereotactic radiosurgery (SRS).","volume":"36","author":"Seung","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"crv190008r13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"crv190008r14","article-title":"Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review.","volume":"2011","author":"Hall","year":"2011","journal-title":"Int J Surg Oncol"},{"issue":"3","key":"crv190008r15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","article-title":"Imaging-based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with spine stereotactic body radiation therapy (SBRT).","volume":"102","author":"Tseng","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"crv190008r16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1748-717X-6-172","article-title":"Clinical practice of image-guided spine radiosurgery: results from an international research consortium.","volume":"6","author":"Guckenberger","year":"2011","journal-title":"Radiat Oncol"},{"key":"crv190008r17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/1471-2407-12-530","article-title":"Fractionated radiosurgery for painful spinal metastases: DOSIS\u2014a phase II trial.","volume":"12","author":"Guckenberger","year":"2012","journal-title":"BMC Cancer"},{"issue":"2","key":"crv190008r18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","article-title":"Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.","volume":"128","author":"Sprave","year":"2018","journal-title":"Radiother Oncol"},{"issue":"2","key":"crv190008r19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","article-title":"Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice.","volume":"85","author":"Sahgal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"crv190008r20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.semradonc.2015.11.010","article-title":"Estimated risk level of unified stereotactic body radiation therapy dose tolerance limits for spinal cord.","volume":"26","author":"Grimm","year":"2016","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"crv190008r21","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3171\/2015.10.SPINE141261","article-title":"Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.","volume":"24","author":"Jawad","year":"2016","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"crv190008r22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","article-title":"Stereotactic body radiotherapy for de novo spinal metastases: systematic review.","volume":"27","author":"Husain","year":"2017","journal-title":"J Neurosurg Spine"},{"issue":"2","key":"crv190008r23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ijrobp.2015.05.035","article-title":"Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery.","volume":"93","author":"Moussazadeh","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"crv190008r24","doi-asserted-by":"crossref","DOI":"10.3171\/2016.9.FOCUS16369","article-title":"The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.","volume":"42","author":"Yamada","year":"2017","journal-title":"Neurosurg Focus"},{"issue":"1","key":"crv190008r25","doi-asserted-by":"crossref","DOI":"10.3171\/2016.10.FOCUS16359","article-title":"Frequency of symptomatic vertebral body compression fractures requiring intervention following single-fraction stereotactic radiosurgery for spinal metastases.","volume":"42","author":"Virk","year":"2017","journal-title":"Neurosurg Focus"},{"issue":"2","key":"crv190008r26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases.","volume":"24","author":"Chow","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"crv190008r27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.prro.2013.05.001","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results.","volume":"4","author":"Ryu","year":"2014","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"crv190008r28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/SPI-07\/08\/151","article-title":"Phase I\/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure.","volume":"7","author":"Chang","year":"2007","journal-title":"J Neurosurg Spine"},{"key":"crv190008r29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/B978-0-12-811161-1.00016-5","article-title":"Management\u2014spinal metastases.","volume":"149","author":"Nater","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"9","key":"crv190008r30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s007010050199","article-title":"Surgical results for spinal metastases.","volume":"140","author":"Klekamp","year":"1998","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"crv190008r31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/2010.9.SPINE091005","article-title":"Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient.","volume":"14","author":"Sahgal","year":"2011","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"crv190008r32","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ijrobp.2016.03.027","article-title":"Postoperative stereotactic body radiation therapy (SBRT) for spine metastases: a critical review to guide practice.","volume":"95","author":"Redmond","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"crv190008r33","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.ijrobp.2016.03.022","article-title":"Stereotactic body radiation therapy for spinal metastases in the postoperative setting: a secondary analysis of mature phase 1-2 trials.","volume":"95","author":"Tao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"crv190008r34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ons\/opy137","article-title":"Hybrid therapy for metastatic epidural spinal cord compression: technique for separation surgery and spine radiosurgery.","volume":"16","author":"Barzilai","year":"2019","journal-title":"Oper Neurosurg (Hagerstown)"},{"issue":"2","key":"crv190008r35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.21037\/jss","article-title":"Timing of surgery and radiotherapy in the management of metastatic spine disease: expert opinion.","volume":"4","author":"Lee","year":"2018","journal-title":"J Spine Surg"},{"issue":"11","key":"crv190008r36","first-page":"1","article-title":"Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: a systematic review.","volume":"16","author":"Health Quality Ontario","year":"2016","journal-title":"Ont Health Technol Assess Ser"},{"issue":"1","key":"crv190008r37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3171\/2017.5.SPINE1746","article-title":"Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis.","volume":"28","author":"Barzilai","year":"2018","journal-title":"J Neurosurg Spine"},{"issue":"4","key":"crv190008r38","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","article-title":"Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.","volume":"27","author":"Myrehaug","year":"2017","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"crv190008r39","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ijrobp.2005.03.034","article-title":"Spinal reirradiation after short-course RT for metastatic spinal cord compression.","volume":"63","author":"Rades","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"crv190008r40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/jpm.2015.28999.sml","article-title":"ACR Appropriateness Criteria\u00ae metastatic epidural spinal cord compression and recurrent spinal metastasis.","volume":"18","author":"Lo","year":"2015","journal-title":"J Palliat Med"},{"issue":"1","key":"crv190008r41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijrobp.2011.10.080","article-title":"Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis.","volume":"84","author":"Huisman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"crv190008r42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ijrobp.2008.09.020","article-title":"Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases.","volume":"74","author":"Sahgal","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"crv190008r43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clon.2017.11.005","article-title":"Re-irradiation of vertebral body metastases: treatment in the radiosurgery era.","volume":"30","author":"Myrehaug","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"crv190008r44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2015.03.029","article-title":"Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases.","volume":"93","author":"Thibault","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"crv190008r45","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.03.022","article-title":"Pain flare is a common adverse event in steroid-na\u00efve patients after spine stereotactic body radiation therapy: a prospective clinical trial.","volume":"86","author":"Chiang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"crv190008r46","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ijrobp.2014.07.037","article-title":"Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1\/2 trials.","volume":"90","author":"Pan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"crv190008r47","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s00520-015-2659-z","article-title":"Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study.","volume":"23","author":"Khan","year":"2015","journal-title":"Support Care Cancer"},{"issue":"3","key":"crv190008r48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/neuros\/nyx493","article-title":"Vertebral compression fracture after spine stereotactic body radiation therapy: a review of the pathophysiology and risk factors.","volume":"83","author":"Faruqi","year":"2018","journal-title":"Neurosurgery"},{"issue":"27","key":"crv190008r49","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score.","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"issue":"22","key":"crv190008r50","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1200\/JCO.2010.34.3897","article-title":"Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group.","volume":"29","author":"Fourney","year":"2011","journal-title":"J Clin Oncol"},{"key":"crv190008r51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-717X-9-69","article-title":"Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases.","volume":"9","author":"Fisher","year":"2014","journal-title":"Radiat Oncol"},{"issue":"3","key":"crv190008r52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ijrobp.2015.02.016","article-title":"Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy.","volume":"92","author":"Pollom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"crv190008r53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT).","volume":"87","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"crv190008r54","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ijrobp.2016.01.038","article-title":"Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the Eastern Cooperative Oncology Group (ECOG).","volume":"95","author":"Anker","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"crv190008r55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00066-018-01422-5","article-title":"Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries.","volume":"195","author":"Kroeze","year":"2019","journal-title":"Strahlenther Onkol"},{"issue":"19","key":"crv190008r56","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1158\/1078-0432.CCR-11-1468","article-title":"Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design.","volume":"17","author":"Chaft","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"16","key":"crv190008r57","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","article-title":"Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the Spine Response Assessment in Neuro-oncology (SPINO) group.","volume":"16","author":"Thibault","year":"2015","journal-title":"Lancet Oncol"},{"issue":"2","key":"crv190008r58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"crv190008r59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7150\/jca.1.80","article-title":"Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST.","volume":"1","author":"Costelloe","year":"2010","journal-title":"J Cancer"},{"issue":"4","key":"crv190008r60","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ijrobp.2016.07.034","article-title":"A study of pseudoprogression after spine stereotactic body radiation therapy.","volume":"96","author":"Bahig","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"crv190008r61","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.ijrobp.2011.02.008","article-title":"Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases.","volume":"82","author":"Chow","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"crv190008r62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ctrv.2016.11.013","article-title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review.","volume":"53","author":"Kroeze","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"crv190008r63","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3171\/2016.4.SPINE16229","article-title":"Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.","volume":"25","author":"Miller","year":"2016","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"crv190008r64","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1464-410X.2010.09895.x","article-title":"Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma.","volume":"108","author":"Staehler","year":"2011","journal-title":"BJU Int"},{"key":"crv190008r84","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2016.11.003","article-title":"The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: what do we know and where are we going?","volume":"52","author":"Hong","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"crv190008r90","article-title":"Immunomodulatory effects of stereotactic body radiation therapy: preclinical insights and clinical opportunities [published online March 2, 2019].","author":"Marciscano","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"crv190008r91","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma.","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"crv190008r92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21037\/cco","article-title":"Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma.","volume":"7","author":"Yeo","year":"2018","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"crv190008r93","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13014-019-1227-y","article-title":"Novel stereotactic body radiation therapy (SBRT)\u2013based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.","volume":"14","author":"Tubin","year":"2019","journal-title":"Radiat Oncol"},{"key":"crv190008r94","doi-asserted-by":"publisher","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"crv190008r95","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.ijrobp.2018.04.038","article-title":"Stereotactic ablative radiation therapy induces systemic differences in peripheral blood immunophenotype dependent on irradiated site.","volume":"101","author":"McGee","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"crv190008r65","unstructured":"SRS and nivolumab in treating patients with newly diagnosed melanoma metastases in the brain or spine. Clinicaltrials.gov identifier: NCT02716948. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02716948. Updated July 26, 2019. Accessed November 1, 2018."},{"key":"crv190008r66","unstructured":"Single-fraction IMRT versus external beam radiotherapy for patients with spine bone metastases (SMART). Clinicaltrials.gov identifier: NCT02358720. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02358720. Updated February 9, 2015. Accessed November 1, 2018."},{"key":"crv190008r67","unstructured":"Stereotactic body radiotherapy (SBRT) for spinal\/para-spinal metastases (spine SBRT). Clinicaltrials.gov identifier: NCT01290562. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01290562. Updated May 3, 2017. Accessed November 1, 2018."},{"key":"crv190008r68","unstructured":"Spinal met_radiosurgery\/SBRT study. Clinicaltrials.gov identifier: NCT01231061. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01231061. Updated July 24, 2014. Accessed November 1, 2018."},{"key":"crv190008r69","unstructured":"A phase II study of spinal radiosurgery (RAD0408). Clinicaltrials.gov identifier: NCT00573872. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00573872. Updated December 5, 2017. Accessed November 1, 2018."},{"key":"crv190008r70","unstructured":"Stereotactic radiosurgery in treating patients with spinal metastases. Clinicaltrials.gov identifier: NCT00853528. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00853528. Updated July 19, 2017. Accessed November 1, 2018."},{"key":"crv190008r71","unstructured":"Image-guided radiosurgery or stereotactic body radiation therapy in treating patients with localized spine metastasis. Clinicaltrials.gov identifier: NCT00922974. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00922974. Updated June 19, 2019. Accessed November 1, 2018."},{"key":"crv190008r72","unstructured":"Stereotactic body radiotherapy for spine tumors. Clinicaltrials.gov identifier: NCT01347307. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01347307. Updated September 25, 2017. Accessed November 1, 2018."},{"key":"crv190008r73","unstructured":"A prospective study using implanted fiducial markers to assess treatment accuracy and esophageal toxicity in spinal stereotactic body radiation therapy. Clinicaltrials.gov identifier: NCT01624220. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01624220. Updated May 10, 2019. Accessed November 1, 2018."},{"key":"crv190008r74","unstructured":"Evaluation of single session stereotactic body radiotherapy. Clinicaltrials.gov identifier: NCT00492817. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00492817. Updated May 9, 2019. Accessed November 1, 2018."},{"key":"crv190008r75","unstructured":"Conformal high dose intensity modulated radiation therapy for disease to thoracic and lumbar spine. Clinicaltrials.gov identifier: NCT01654068. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01654068. Updated April 19, 2019. Accessed November 1, 2018."},{"key":"crv190008r76","unstructured":"Phase I study of feasibility of single session spine stereotactic radiosurgery (SSRS) in the primary management in patients with inoperable, previously unirradiated metastatic epidural spinal cord compression (MESCC). Clinicaltrials.gov identifier: NCT01254903. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01254903. Updated May 9, 2019. Accessed November 1, 2018."},{"key":"crv190008r77","unstructured":"Radiotherapy for solid tumor spine metastases. Clinicaltrials.gov identifier: NCT01752036. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01752036. Updated November 7, 2018. Accessed November 1, 2018."},{"key":"crv190008r78","unstructured":"Randomized study comparing two dosing schedules for hypofractionated image-guided radiation therapy. Clinicaltrials.gov identifier: NCT01223248. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01223248. Updated June 5, 2019. Accessed November 1, 2018."},{"key":"crv190008r79","unstructured":"A study to quantify tumour perfusion for spine metastasis treated with stereotactic body radiotherapy (SBRT). Clinicaltrials.gov identifier: NCT03072979. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03072979. Updated March 8, 2017. Accessed November 1, 2018."},{"key":"crv190008r80","unstructured":"Study of image-guided SBRT for vertebral metastases. Clinicaltrials.gov identifier: NCT02616887. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02616887. Updated October 24, 2018. Accessed November 1, 2018."},{"key":"crv190008r81","unstructured":"Stereotactic body radiation therapy and vertebroplasty in treating patients with localized spinal metastasis. Clinicaltrials.gov identifier: NCT00855803. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00855803. Updated January 7, 2019. Accessed November 1, 2018."},{"key":"crv190008r82","unstructured":"Study comparing stereotactic body radiotherapy vs conventional palliative radiotherapy (CRT) for spinal metastases. Clinicaltrials.gov identifier: NCT02512965. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02512965. Updated September 30, 2019. Accessed November 1, 2018."},{"key":"crv190008r83","unstructured":"Evaluating stereotactic body radiation therapy for oligometastatic disease of the bone. Clinicaltrials.gov identifier: NCT02880319. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02880319. Updated January 25, 2019. Accessed November 1, 2018."},{"key":"crv190008r85","unstructured":"Stereotactic ablative radiotherapy for comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET 10). Clinicaltrials.gov identifier: NCT03721341. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03721341. Updated October 28, 2019. Accessed November 1, 2018."},{"key":"crv190008r86","unstructured":"Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (SARON). Clinicaltrials.gov identifier: NCT02417662. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02417662. Updated October 17, 2019. Accessed November 1, 2018."},{"key":"crv190008r87","unstructured":"Conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases (CORE). Clinicaltrials.gov identifier: NCT02759783. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02759783. Updated August 21, 2019. Accessed November 1, 2018."},{"key":"crv190008r88","unstructured":"Standard of care therapy with or without stereotactic radiosurgery and\/or surgery in treating patients with limited metastatic breast cancer. Clinicaltrials.gov identifier: NCT02364557. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02364557. Updated November 6, 2019. Accessed November 1, 2018."},{"key":"crv190008r89","unstructured":"Maintenance chemotherapy with or without local consolidative therapy in treating patients with stage IV non\u2013small cell lung cancer. Clinicaltrials.gov identifier: NCT03137771. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03137771. Updated September 5, 2019. Accessed November 1, 2018."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2757845\/jamaoncology_glicksman_2020_rv_190008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:00:13Z","timestamp":1722254413000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2757845"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.5351","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}